About Jong-Mu Sun
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Jong-Mu Sun
During the past decade, Jong-Mu Sun conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Jong-Mu Sun"
#1 collaborator was "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Jong-Mu Sun
According to Clinical.Site data, the most researched conditions in "Jong-Mu Sun" are
"Brain Metastases" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Non-small Cell Lung Cancer Metastatic" (1 trials). Many other conditions were trialed in "Jong-Mu Sun" in a lesser frequency.
Clinical Trials Intervention Types at Jong-Mu Sun
Most popular intervention types in "Jong-Mu Sun" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Dacomitinib" (1 trials), "Nivolumab" (1 trials), "Pembrolizumab plus chemotherapy" (1 trials) and "Placebo plus chemotherapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jong-Mu Sun
The vast majority of trials in "Jong-Mu Sun" are
3 trials for "All" genders.
Clinical Trials Status at Jong-Mu Sun
Currently, there are NaN active trials in "Jong-Mu Sun".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Jong-Mu Sun,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Jong-Mu Sun, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".